MedPath

Effect of Siddha Varmam therapy for the treatment of shoulder pain and disability.

Phase 2
Conditions
Health Condition 1: M750- Adhesive capsulitis of shoulder
Registration Number
CTRI/2020/08/027350
Lead Sponsor
Central Council for Research in Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with shoulder pain > 70% SPADI lasting for more than a month and range of motion limited at least 25% in one or more directions measured using Goniometer.

2.Duration of complaints > 3 months

Exclusion Criteria

1.History of Rotator tear, traumatic history, history of surgery in shoulder joint in the preceding 1 year, patients who underwent Varmam treatment/any other external treatment for kumbavatham within last three months prior to enrolment, history of fracture in clavicle, humerus, scapula and bones of upper limbs, osteoarthritis shoulder, Cervical neuropathy, paralysis, neurological disorder, shockwave or injection therapy in shoulder joint, Ischemic Heart Disease, rheumatoid arthritis, dislocation, osteoporosis, lifting heavy weight in routine life, pregnancy, lactation.

2.Intervention model: parallel assignment.

3.Arms: 2 (Experimental arm-2)

4.Experimental arm 1: Thailam Application.

5.Experimental arm 2: Varmam + Thailam Application.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
â?¢Reduction in shoulder pain and improvement in range of movements of shoulder joint. It is assessed by Shoulder Pain and Disability Index â?? SPADI.Timepoint: Screening, At the time of recruitment, End of the trial period. Time point: 6 weeks
Secondary Outcome Measures
NameTimeMethod
â?¢Quality of life of trial participants. It will be assessed by Quality of life questionnaire. (SF-36 questionnaire). <br/ ><br> <br/ ><br>â?¢End point classification: SPADI, SF-36, Safety Parameters. <br/ ><br>â?¢Time schedule of enrolment: 18 months. Project duration: 3 years. <br/ ><br>â?¢Treatment duration: 3 days in a week on alternate days for 6 weeks, ie 18visits <br/ ><br>Timepoint: At the time of recruitment and at the end of the trial period. <br/ ><br>Time point: 6 weeks
© Copyright 2025. All Rights Reserved by MedPath